Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.42 +0.01 (+0.71%)
As of: Nov 10, 2026 · 3:12 PM EST

Tvardi Therapeutics (TVRD) Restructuring Costs (2024)

Updated

Tvardi Therapeutics (TVRD) recorded Restructuring Costs of -$124,000 in Q4 2024.

Analysis

Tvardi Therapeutics (TVRD) Restructuring Costs (2024) Analysis & Trends

For FY2024, Tvardi Therapeutics reported Restructuring Costs of $5.57 million.

  • Per Business Quant, the preceding three quarters came in at $707,000 (Q3 2024), $2.58 million (Q2 2024) and $2.4 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Tvardi Therapeutics 12.48 Mn -95.62 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -124,000.00
Sep 30, 2024 707,000.00
Jun 30, 2024 2.58 Mn
Mar 31, 2024 2.40 Mn
API Access

Tvardi Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TVRD&period=max&api_key=YOUR_API_KEY